Some question the safety of AstraZeneca's just-launched DARE-19 study testing whether the type 2 diabetes drug dapagliflozin will reduce adverse outcomes of COVID-19.
from WebMD Health https://www.webmd.com/lung/news/20200430/new-study-of-diabetes-drug-for-covid-19-raises-eyebrows?src=RSS_PUBLIC
0 Comments:
Post a Comment